SecProbe.io

Probe score transparency
Intelligence Terminal Search Topics Monthly Activity About

Probe Score Transparency

Calidi Biotherapeutics, Inc. (CLDI)
Score window: May. 30, 2025 to May. 29, 2026

Probe Score
4.5 / 10
Letters
3
Latest Activity
Aug. 19, 2025
Version
v1

Score Breakdown

Letter Count
3.0
Sentiment / Tone
1.5
Keywords
0.0
Signals
0.0
Notable 8-K Modifier
0.0
Notable 8-K Count
0

Matched Signals

No stored keyword or signal matches were recorded for this score.

Filings In This Window

DateFormSentimentUrgencySummaryOpen
Aug. 19, 2025 CORRESP Neutral/Informational Moderate Calidi Biotherapeutics, Inc. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-1, which was filed on August 15, 2025. T… Read Filing EDGAR
Aug. 19, 2025 CORRESP Neutral/Informational Moderate Calidi Biotherapeutics, Inc. has submitted a request to the SEC for the acceleration of the effective date of their Registration Statement on Form S-1. They are seeking to have it… Read Filing EDGAR
Jul. 24, 2025 CORRESP Neutral/Informational Moderate Calidi Biotherapeutics, Inc. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-3. They are seeking for it to be declare… Read Filing EDGAR
Jul. 22, 2025 UPLOAD Neutral/Informational Low The SEC has communicated to Calidi Biotherapeutics, Inc. that it will not review their registration statement filed on July 18, 2025. The letter emphasizes the company's responsib… Read Filing EDGAR
Jul. 10, 2025 CORRESP Neutral/Informational Moderate Calidi Biotherapeutics, Inc. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-1. They are seeking for it to be declare… Read Filing EDGAR
Jul. 8, 2025 UPLOAD Neutral/Informational Low The SEC correspondence dated July 8, 2025, informs Calidi Biotherapeutics, Inc. that their registration statement on Form S-1, filed on July 3, 2025, will not be reviewed by the S… Read Filing EDGAR
Jul. 8, 2025 UPLOAD Neutral/Informational Low The SEC has communicated to Calidi Biotherapeutics, Inc. that they do not intend to review the company's draft registration statement submitted on July 2, 2025. The SEC has reques… Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in the score window.